PharmaShots | Incisive News in 3 Shots

Subscribe Now

Erasca

Erasca Partners with Novartis for the Development of Naporafenib Combinations in a Series of SEACRAFT Studies to Treat Solid Tumors

Erasca Partners with Novartis for the Development of Naporafenib Combinations in a Series of SEACRAFT Studies to Treat Solid Tumor...

February 15, 2024

Erasca Entered into a Research Collaboration with MD Anderson for RAS/MAPK-Driven Cancers

Erasca Entered into a Research Collaboration with MD Anderson for RAS/MAPK-Driven Cancers

August 24, 2022

Erasca Entered into a Clinical Trial Collaboration and Supply Agreement with Eli Lilly to Evaluate ERAS-601 + Cetuximab for Cancer

Erasca Entered into a Clinical Trial Collaboration and Supply Agreement with Eli Lilly to Evaluate ERAS-601 + Cetuximab for Cancer

July 19, 2022

Erasca Entered into a Clinical Trial Collaboration and Supply Agreement with Eli Lilly to Evaluate ERAS-007 and Erbitux (cetuximab) for Metastatic Colorectal Cancer

Erasca Entered into a Clinical Trial Collaboration and Supply Agreement with Eli Lilly to Evaluate ERAS-007 and Erbitux (cetuximab...

March 11, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us